Phico Therapeutics Ltd.

Four new sources of venture capital for biotechnology companies were announced during the first half of May with more than $1.7bn in fresh funding for start-ups and growing early-stage firms. Abingwor

The flow of venture capital into biopharmaceutical companies has been astonishing – breaking the prior record by a wide margin in 2020 – and, so far, 2021 looks like it is on track to leave a big gap

The incidence of C. difficile-associated disease is on the rise. With existing therapies losing their punch, some biotechs are stepping up to fill the void. By Ellen Foster Licking Ask an infectious d

Fighting antibiotic-resistant infections with a bacteriophage-delivered protein. Researchers first began exploring the use of bacteriophage to fight bacterial infection over 80 years ago. Bacteriophag